GL1X · GenesisL1 explorer

MolNFT v1 · #110860 · protein

Crystal structure of V30M mutated transthyretin with bromide in complex with alpha-mangostin

4Y9C: “Crystal structure of V30M mutated transthyretin with bromide in complex with alpha-mangostin”. X-ray diffraction, 2 ligands (MKS, BR), 3 pockets (best druggability 0.38). MolNFT v1 #110860 on GenesisL1: 3D structure, binding sites…

PDB
4Y9C
Type
protein
Length
227 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
MKS, BR
Pockets
3 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1156% helix, 53% strandP02766
BTransthyretinprotein1126% helix, 53% strandP02766

Ligands and binding sites

  • MKS · 1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one · ligand · 2 copies · chains A, B
  • BR · Bromide ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.380.7716empty
2940.350.7424empty
3590.260.7319BR

Interfaces

1 interface between chains.

  • A–B · 934 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4Y9C · Crystal structure of V30M mutated transthyretin with bromide in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.